103 related articles for article (PubMed ID: 20816501)
1. Mucinous adenocarcinoma of the ovary.
Sholi A; Martino MA; Pirigyi M; Rosenblum NG; Markman M; Peterson CS; Bradbury AR; Morris GJ
Semin Oncol; 2010 Aug; 37(4):314-20. PubMed ID: 20816501
[No Abstract] [Full Text] [Related]
2. Borderline mucinous tumour with mural nodule of signet ring adenocarcinoma.
Ong NC; Ostör AG
Aust N Z J Obstet Gynaecol; 2002 Nov; 42(5):561-2. PubMed ID: 12495115
[No Abstract] [Full Text] [Related]
3. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
4. FOLFOX for stage II colon cancer? A commentary on the recent FDA approval of oxaliplatin for adjuvant therapy of stage III colon cancer.
Grothey A; Sargent DJ
J Clin Oncol; 2005 May; 23(15):3311-3. PubMed ID: 15908645
[No Abstract] [Full Text] [Related]
5. Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin.
Sugarbaker PH; Bijelic L; Chang D; Yoo D
J Surg Oncol; 2010 Nov; 102(6):576-81. PubMed ID: 20737420
[TBL] [Abstract][Full Text] [Related]
6. [A case of well differentiated mucinous cystadenocarcinoma of the ovary with intratumoral DNA heterogeneity].
Takahashi Y; Yamade I; Mitsuno N; Yokoe Y; Takenaka A; Noda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Jun; 47(6):569-72. PubMed ID: 7608623
[No Abstract] [Full Text] [Related]
7. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
[No Abstract] [Full Text] [Related]
8. [Clinical and pathological features of borderline ovarian tumors].
Li Y; Cui H; Shen DH; Zhao Y; Wei LH; Qian HN
Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):81-4. PubMed ID: 12783693
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant measures after primary surgery of ovarian cancer].
Bauknecht T
Gynakologe; 1994 Apr; 27(2):70-5. PubMed ID: 8039745
[No Abstract] [Full Text] [Related]
10. [Adjuvant therapy for colon cancer].
Lordick F; Rosenberg R; Stein HJ; Peschel C; Siewert JR
Dtsch Med Wochenschr; 2004 Oct; 129(44):2366-71. PubMed ID: 15497107
[No Abstract] [Full Text] [Related]
11. Multi-modality therapy for metastatic colorectal cancer-ready for prime time?
Chua TC; Marshall JL; Marshall MB; Esquivel J
Am Surg; 2010 Jul; 76(7):777-8. PubMed ID: 20698392
[No Abstract] [Full Text] [Related]
12. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
Gao KF; Liu FY; Chen FJ; Feng YL
Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
[TBL] [Abstract][Full Text] [Related]
13. A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.
Catania C; Pelosi G; Fazio N; Biffi R; Spitaleri G; Noberasco C; Zampino MG; Maggioni A; Trifirò G; Toffalorio F; Vigna PD; De Braud F; De Pas T
Acta Oncol; 2010; 49(1):120-1. PubMed ID: 20100147
[No Abstract] [Full Text] [Related]
14. Small cell carcinoma of pulmonary type inside a microinvasive mucinous cystadenocarcinoma of the ovary: a case report.
Grandjean M; Legrand L; Waterkeyn M; Baurain JF; Jadoul P; Donnez J; Marbaix E
Int J Gynecol Pathol; 2007 Oct; 26(4):426-31. PubMed ID: 17885493
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy of oxaliplatin and 5-fluorouracil may be an effective regimen for mucinous adenocarcinoma of the ovary: a potential treatment strategy.
Sato S; Itamochi H; Kigawa J; Oishi T; Shimada M; Sato S; Naniwa J; Uegaki K; Nonaka M; Terakawa N
Cancer Sci; 2009 Mar; 100(3):546-51. PubMed ID: 19154404
[TBL] [Abstract][Full Text] [Related]
16. [A prospective study of FOLFOX7 scheme as neoadjuvant chemotherapy for stage III gastric adenocarcinoma].
Liu YH
Zhonghua Wai Ke Za Zhi; 2009 Sep; 47(17):1305-8. PubMed ID: 20092724
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
18. [Borderline tumors of the ovary].
Yokoyama T; Oshita T; Nogawa T; Hiura M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():476-9. PubMed ID: 15535291
[No Abstract] [Full Text] [Related]
19. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
20. [Clinical behavior of serous and mucinous borderline tumors of the ovary with diploid DNA stem line. Follow-up studies after organ preserving and non-organ preserving therapy].
Mecke H; Börner-Klaussner B; Grosse G; Nadjari B; Hauptmann S
Zentralbl Gynakol; 2000; 122(5):274-9. PubMed ID: 10857214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
